Delivery Order SPE2DB24D2105-SPE2DB25FAPUZ
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 60 tablets of the medication Dasatinib 50 mg. The contract has a ceiling value of $40,984.03 and a completion date of July 2, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and there is no information provided about any subcontractors. This delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dasatinib 140 mg tablets, a medication used to treat certain types of cancer. The contract has a ceiling value of $11,239.87 and a period of performance ending on July 3, 2025. The contract is a firm fixed-price delivery order, meaning the price will not change regardless of the...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Dasatinib 100 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $37,364.76, with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DASATINIB 80 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price of $12,790.96 and a period of performance ending on July 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a $29,367.09 firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of DASATINIB 100 MG TABLET 30S medication. The contract has an ultimate completion date of July 7, 2025 and is not set aside. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- The Defense Logistics Agency awarded a delivery order valued at $9,193.03 to AmerisourceBergen Drug Corp for Dasatinib 50 mg tablets (60-count supply) on August 11, 2025, with a completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the delivery of Sprycel (Dasatinib) 100 mg tablets. The contract, valued at $45,165.44, has a completion date of November 22, 2022 and is a Firm Fixed Price arrangement. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of 60-count tablets of the medication Sprycel (dasatinib) 50 mg. The contract has a ceiling value of $9,692.86 and runs through August 30, 2024. It is a delivery order contract with a firm fixed-price pricing type. The contract does not have a set-aside designation. AmerisourceBergen, through its Corporate Office division, will...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $59,674.44 and is a firm fixed-price delivery order with a period of performance through June 17, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,662.80 and a completion date of June 17, 2025. The contract is not set aside and allows for the delivery of a range of pharmaceutical products and medical supplies to support federal agencies, including the Defense Health Agency and U.S. Coast Guard....
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAPUZDelivery Order
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of 100 mg Dasatinib tablets, with a ceiling value of $27,673.65 and a period of performance through June 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a for-profit corporate entity that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense Health Agency and U.S. Coast Guard. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.7k | 6/24/25 |